20 min listen
Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s Pipeline
Oculis CEO Riad Sherif Talks About Novartis, Alcon, and What’s Promising in His Company’s Pipeline
ratings:
Length:
19 minutes
Released:
Apr 17, 2019
Format:
Podcast episode
Description
Oculis CEO Riad Sherif, who once worked for Novartis and Alcon, reveals which company he’d invest in following the spin-off of the latter from the former – but mostly about the Switzerland-based start-up’s promising new pipeline for DME, post-surgery inflammation, and dry eye.
Released:
Apr 17, 2019
Format:
Podcast episode
Titles in the series (100)
Donnenfeld Bullish on Ophthalmic Innovation by OIS Podcast | Ophthalmology's leading Podcast